Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription


3 J Infect Dis
2 J Virol
1 Nat Med
2 Pediatr Infect Dis J
1 Pediatrics
1 PLoS Biol
1 PLoS Comput Biol
2 Proc Natl Acad Sci U S A
13 Vaccine
1 Virology

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    J Infect Dis

  1. ZHANG Y, Zhou Y, Chen J, Wu J, et al
    Vaccination Shapes Within-Host SARS-CoV-2 Diversity of Omicron BA.2.2 Breakthrough Infection.
    J Infect Dis. 2023 Dec 27:jiad572. doi: 10.1093.
    PubMed         Abstract available

  2. WIDAGDO W, Bastian AR, Jastorff AM, Scheys I, et al
    Concomitant Administration of Ad26.RSV.preF/RSV preF Protein Vaccine and High-dose Influenza Vaccine in Adults 65 Years and Older: a Noninferiority Trial.
    J Infect Dis. 2023 Dec 22:jiad594. doi: 10.1093.
    PubMed         Abstract available

  3. HERMIDA N, Ferguson M, Leroux-Roels I, Pagnussat S, et al
    Safety and Immunogenicity of Respiratory Syncytial Virus Pre-fusion Maternal Vaccine Co-administered with Diphtheria-Tetanus-Pertussis Vaccine: A Phase 2 Study.
    J Infect Dis. 2023 Dec 22:jiad560. doi: 10.1093.
    PubMed         Abstract available

    J Virol

  4. HOU YN, Jin YQ, Zhang XF, Tang F, et al
    Chimeric virus-like particles of human norovirus constructed by structure-guided epitope grafting elicit cross-reactive immunity against both GI.1 and GII.4 genotypes.
    J Virol. 2023;97:e0093823.
    PubMed         Abstract available

  5. PENG Q, Fan B, Song X, He W, et al
    Genetic signatures associated with the virulence of porcine epidemic diarrhea virus AH2012/12.
    J Virol. 2023 Sep 21:e0106323. doi: 10.1128/jvi.01063.
    PubMed         Abstract available


  6. STEWART TG, Rebolledo PA, Mourad A, Lindsell CJ, et al
    Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19: The ACTIV-6 Randomized Clinical Trial.
    JAMA. 2023 Nov 17:e2323363. doi: 10.1001/jama.2023.23363.
    PubMed         Abstract available

    Nat Med

  7. DUCH R, Asiedu E, Nakamura R, Rouyard T, et al
    Author Correction: Financial incentives for COVID-19 vaccines in a rural low-resource setting: a cluster-randomized trial.
    Nat Med. 2023 Dec 22. doi: 10.1038/s41591-023-02772.

    Pediatr Infect Dis J

  8. ZIMMERMANN P, Pittet LF, Jakob W, Messina NL, et al
    The Effect of Bacille Calmette-Guerin Vaccination on the Composition of the Intestinal Microbiome in Neonates From the MIS BAIR Trial.
    Pediatr Infect Dis J. 2023 Dec 25. doi: 10.1097/INF.0000000000004223.
    PubMed         Abstract available

  9. ZAMBRANO LD, Newhams MM, Simeone RM, Fleming-Dutra KE, et al
    Characteristics and Clinical Outcomes of Vaccine-Eligible US Children Under-5 Years Hospitalized for Acute COVID-19 in a National Network.
    Pediatr Infect Dis J. 2023 Dec 25. doi: 10.1097/INF.0000000000004225.
    PubMed         Abstract available


  10. FUETA P
    Okemena's Legacy: A Resident's Fight for Vaccine Advocacy.
    Pediatrics. 2023 Dec 27:e2022059509. doi: 10.1542/peds.2022-059509.

    PLoS Biol

  11. SIMMONS HC, Watanabe A, Oguin Iii TH, Van Itallie ES, et al
    A new class of antibodies that overcomes a steric barrier to cross-group neutralization of influenza viruses.
    PLoS Biol. 2023;21:e3002415.
    PubMed         Abstract available

    PLoS Comput Biol

  12. MULBERRY N, Rutherford AR, Colijn C
    Pneumococcal population dynamics: Investigating vaccine-induced changes through multiscale modelling.
    PLoS Comput Biol. 2023;19:e1011755.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  13. YE Z, Bonam SR, McKay LGA, Plante JA, et al
    Monovalent SARS-COV-2 mRNA vaccine using optimal UTRs and LNPs is highly immunogenic and broadly protective against Omicron variants.
    Proc Natl Acad Sci U S A. 2023;120:e2311752120.
    PubMed         Abstract available

  14. FINNEY J, Moseman AP, Kong S, Watanabe A, et al
    Protective human antibodies against a conserved epitope in pre- and postfusion influenza hemagglutinin.
    Proc Natl Acad Sci U S A. 2024;121:e2316964120.
    PubMed         Abstract available


  15. MIRANDA MCR, Nunes CM, Santos LF, da Silva LB, et al
    Ordered mesoporous silicas for potential applications in solid vaccine formulations.
    Vaccine. 2023 Dec 24:S0264-410X(23)01478-0. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  16. SEESKIN ZH, Ganesh N, Maitra P, Herman P, et al
    Estimating county-level vaccination coverage using small area estimation with the National Immunization Survey-Child.
    Vaccine. 2023 Dec 23:S0264-410X(23)01492-5. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  17. NGUYEN KH, Coy KC, Black CL, Scanlon P, et al
    Comparison of adult hesitancy towards COVID-19 vaccines and vaccines in general in the USA.
    Vaccine. 2023 Dec 23:S0264-410X(23)01488-3. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  18. MAHMOOD S, Skinner P, Warren CJ, Mayers J, et al
    In vivo challenge studies on vaccinated chickens indicate a virus genotype mismatched vaccine still offers significant protection against NDV.
    Vaccine. 2023 Dec 23:S0264-410X(23)01483-4. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  19. KACHKO A, Selvaraj P, Liu S, Kim J, et al
    Vaccine-associated respiratory pathology correlates with viral clearance and protective immunity after immunization with self-amplifying RNA expressing the spike (S) protein of SARS-CoV-2 in mouse models.
    Vaccine. 2023 Dec 22:S0264-410X(23)01498-6. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  20. SEPPALA E, Dahl J, Veneti L, Rydland KM, et al
    Covid-19 and influenza vaccine effectiveness against associated hospital admission and death among individuals over 65 years in Norway: A population-based cohort study, 3 October 2022 to 20 June 2023.
    Vaccine. 2023 Dec 22:S0264-410X(23)01496-2. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  21. LANGLEY JM, Gantt S, Halperin SA, Ward B, et al
    An enveloped virus-like particle alum-adjuvanted cytomegalovirus vaccine is safe and immunogenic: A first-in-humans Canadian Immunization Research Network (CIRN) study.
    Vaccine. 2023 Dec 22:S0264-410X(23)01452-4. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  22. LO E, Brousseau N, Defay F, Fortin E, et al
    Neighborhood-level vaccine impact on COVID-19 infection and hospital admission in Quebec, Canada, during the Delta and early Omicron periods.
    Vaccine. 2023 Dec 22:S0264-410X(23)01489-5. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  23. LEVITAN B, Hadler SC, Hurst W, Izurieta HS, et al
    The Brighton collaboration standardized module for vaccine benefit-risk assessment.
    Vaccine. 2023 Dec 21:S0264-410X(23)01109-X. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  24. FONSECA HAR, Zimerman A, Monfardini F, Guimaraes HP, et al
    In-Hospital influenza vaccination to prevent cardiorespiratory events in the first 45 days after acute coronary syndrome: A prespecified analysis of the VIP-ACS trial.
    Vaccine. 2023 Dec 27:S0264-410X(23)01531-1. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  25. SHENTON P, Schrader S, Smith J, Alafaci A, et al
    Long term follow up and outcomes of Covid-19 vaccine associated myocarditis in Victoria, Australia: A clinical surveillance study.
    Vaccine. 2023 Dec 27:S0264-410X(23)01516-5. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  26. GHARPURE R, Akumu AO, Dawa J, Gobin S, et al
    Costs of seasonal influenza vaccine delivery in a pediatric demonstration project for children aged 6-23 months - Nakuru and Mombasa Counties, Kenya, 2019-2021.
    Vaccine. 2023 Dec 27:S0264-410X(23)01475-5. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  27. SURTEES TC, Granade CJ, Wells C, Banks M, et al
    CDC COVID-19 vaccination program: Healthcare provider compliance with COVID-19 vaccine requirements and recommendations.
    Vaccine. 2023 Dec 27:S0264-410X(23)01467-6. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available


  28. FAZEL F, Matsuyama-Kato A, Alizadeh M, Boodhoo N, et al
    Efficacy and tolerability of an mRNA vaccine expressing gB and pp38 antigens of Marek's disease virus in chickens.
    Virology. 2023;590:109970.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.